Growth Metrics

Sensus Healthcare (SRTS) Cost of Revenue (2016 - 2025)

Sensus Healthcare has reported Cost of Revenue over the past 10 years, most recently at $10.5 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 23.97% year-over-year to $10.5 million; the TTM value through Dec 2025 reached $18.6 million, down 5.23%, while the annual FY2025 figure was $15.6 million, 10.13% down from the prior year.
  • Cost of Revenue for Q4 2025 was $10.5 million at Sensus Healthcare, up from $1.5 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $13.8 million in Q4 2024 and troughed at -$1.0 million in Q4 2021.
  • A 5-year average of $3.3 million and a median of $2.1 million in 2021 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: tumbled 407.04% in 2021 and later surged 554.06% in 2022.
  • Year by year, Cost of Revenue stood at -$1.0 million in 2021, then surged by 554.06% to $4.8 million in 2022, then dropped by 0.38% to $4.7 million in 2023, then skyrocketed by 191.41% to $13.8 million in 2024, then decreased by 23.97% to $10.5 million in 2025.
  • Business Quant data shows Cost of Revenue for SRTS at $10.5 million in Q4 2025, $1.5 million in Q3 2025, and $4.4 million in Q2 2025.